What Happened?
Cambridge, MA-based IFM-Therapeutics Appointed Gary Glick as Co Founder and Chief Executive Officer
About the Company
At IFM Therapeutics, LLC, we work to improve the lives of patients with inflammatory disorders and cancer by developing transformative medicines that precisely target the innate immune system, the body`s first line of immunological response and an essential component of immune function.
About the Person
Gary Glick is Co Founder and Chief Executive Officer at IFM Therapeutics. Previously, Gary held various senior HR leadership roles in the industry.
Info Source
News
Short Profile